Yamashita et al44 reported that the expression of α‐SMA was markedly higher in an invasive breast cancer dissemination subgroup than in a no dissemination subgroup and that the invasive subgroup had a worse survival rate. The gene discussed is ACTA1; the disease is invasive breast carcinoma.